1. Home
  2. PEBO vs OMER Comparison

PEBO vs OMER Comparison

Compare PEBO & OMER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Peoples Bancorp Inc.

PEBO

Peoples Bancorp Inc.

HOLD

Current Price

$38.31

Market Cap

1.4B

Sector

Finance

ML Signal

HOLD

Logo Omeros Corporation

OMER

Omeros Corporation

HOLD

Current Price

$16.63

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PEBO
OMER
Founded
1902
1994
Country
United States
United States
Employees
N/A
175
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.2B
IPO Year
2005
2008

Fundamental Metrics

Financial Performance
Metric
PEBO
OMER
Price
$38.31
$16.63
Analyst Decision
Hold
Buy
Analyst Count
7
3
Target Price
★ $42.50
$27.50
AVG Volume (30 Days)
427.5K
★ 1.0M
Earning Date
10-20-2026
11-12-2026
Dividend Yield
★ 4.40%
N/A
EPS Growth
N/A
★ 98.15
EPS
★ 1.59
0.77
Revenue
$197,000.00
★ $29,868,000.00
Revenue This Year
$7.39
N/A
Revenue Next Year
$56.09
$73.59
P/E Ratio
$23.99
★ $21.85
Revenue Growth
N/A
★ N/A
52 Week Low
$28.01
$6.24
52 Week High
$42.29
$21.24

Technical Indicators

Market Signals
Indicator
PEBO
OMER
Relative Strength Index (RSI) 55.70 40.16
Support Level $37.53 $16.17
Resistance Level $39.33 $19.81
Average True Range (ATR) 0.71 0.81
MACD 0.30 -0.33
Stochastic Oscillator 93.79 17.18

Price Performance

Historical Comparison
PEBO
OMER

About PEBO Peoples Bancorp Inc.

Peoples Bancorp Inc (Marietta OH) is a financial holding company. As a community bank, it offers a complete line of banking, insurance, investment, and trust solutions through its financial subsidiaries. It offers demand deposit accounts, savings accounts, real estate mortgage loans, merchant credit card transaction processing services, corporate and personal trust services, life, health, property, and casualty insurance products, and brokerage services. The bank also offers telephone and internet-based banking through both personal computers and mobile devices.

About OMER Omeros Corporation

Omeros Corp is an inventive, commercial-stage biotechnology company that discovers and develops first-in-class protein and small-molecule therapeutics for large-market and orphan indications, with particular emphasis on complement-mediated diseases, cancers, and addictive or compulsive disorders. The company's clinical-stage development programs include: narsoplimab, its antibody targeting mannan-binding lectin-associated serine protease 2 (MASP-2), the effector enzyme of the lectin pathway of complement; OMS1029, its long-acting antibody targeting MASP-2; and OMS527, its phosphodiesterase 7 (PDE7) inhibitor program.

Share on Social Networks: